You searched for "interventions"

2097 results found

Ocular adnexal marginal zone b-cell lymphoma

This is a multicentre retrospective study of seven eye centres of 689 patients with ocular adnexal extranodal marginal zone b-cell lymphoma (OA-EMZL). The median follow-up time was 42 months and the median age was 62 years. Fifty-five percent were women;...

Visual acuity conversion to digital acuity

The author proposes a basic set of evidence-based digital acuities for alpha vision to facilitate formatting of visual acuity data uniformly. This work was informed by a review of the literature. A full table provides US and international classification of...

Diagnostic error rates for ROP detection by trainee ophthalmologist in middle-income countries

The purpose of this study was to describe errors in ROP diagnosis made by ophthalmologists-in-training from programmes in middle-income countries including Brazil, the Philippines and Mexico who participated in a tele-education programme. Trainees were tested on 20 cases from a...

Types of nystagmus and associations in a large international database for nystagmus

The authors aimed to characterise a large international cohort of children with nystagmus. Data were taken from a prospective database which was started in 2010. Up to 2020, this contained 1774 patients with nystagmus from 38 US states and 30...

Google searches predict pathology after a solar eclipse

This light-hearted review identified that the Google search term, ‘my eyes hurt’ was trending on 8 April 2024, coinciding with the exact time when a total solar eclipse passed over the US. They identified the subregions that searched this term...

Nordic Pharma Announces CE Mark Approval for Lacrifill® Canalicular Gel, Paving the Way for European Launch

Nordic group B.V – an international pharmaceutical company operating as Nordic Pharma have received CE mark approval for Lacrifill®, a novel dry eye therapy. Lacrifill® is a cross-linked hyaluronic acid gel that temporarily blocks tear drainage by occluding the canalicular...

Sight Sciences at ESCRS

The Sight Sciences team recently returned from an incredibly busy and successful ESCRS congress in Copenhagen. The team were in town to support the MIGS masterclass programme and were pleased to spend time with customers, colleagues and contacts from across...

Sight Sciences at UKEGS

The Sight Sciences team recently returned from an energising UKEGS conference in the wonderful city of Edinburgh. The team were pleased to spend time with customers, colleagues and contacts from across the UK and beyond. Many thanks to everybody who...

OSA dry eye disease group forms for technology providers

Dry eye disease diagnostic and therapy technology providers have formed a specialist OSA and Optic UK group to collaborate and provide optimum support for the profession. Led by Ross Bailey, SCOPE Eyecare Professional Relations and Partnerships Manager, and Nicola Bennett,...

UKNOS Annual Meeting 2027

The UK Neuro-ophthalmology Society (UKNOS) Annual Meeting will take place on Thursday 25th February 2027 at International Students House, Regent’s Park, London. The theme is ‘NEURO-ophthalmology: we see with our brain not our eyes.’ Sessions will include clinical talks, scientific...

American Glaucoma Society (AGS) Annual Meeting 2025

Important Dates September 5, 2024: Abstract Submission and Surgical Video Submission Opens October 10, 2024 : Abstract Submission Site ClosesOctober 17, 2024: Registration and Housing open to AGS Members OnlyOctober 17, 2024: Surgical Video Submission ClosesNovember 15, 2024: Registration and...

Trial of low-concentration bimatoprost and timolol eye gel versus higher concentrations

This is an international, multicentre, randomised, parallel group, investigator-masked study of 554 patients, having insufficient control of intraocular pressure (IOP) with a first-line monotherapy and requiring dual therapy. Two hundred and eighty patients were randomised to receive low concentration (BTFCEG...